Press release: HRP2 recombinant panel now available for malaria rapid diagnostic tests

Press release: HRP2 recombinant panel now available for malaria rapid diagnostic tests

Microcoat and the Foundation for Innovative New Diagnostics (FIND) announce the launch of HRP2 recombinant panel for assessment of the malaria rapid diagnostic test performance in product evaluation and lot testing programs

Read the full press release here:

Microcoat-FIND_press release_04.09.2017-final

MORE NEWS
  • 03Nov

    Microcoat announces the 7th Monocyte-Activation Test Proficiency Test Program

    Read More →
  • 17Okt

    Meet us at the PharmaLab 2022 Düsseldorf/Neuss, Germany

    Read More →
  • 10Okt

    Microcoat announces agreement with Olink to offer innovative proteomic approaches with Olink® Proximity Extension Assay (PEA) technology for pharma partners

    Read More →
  • 29Sep

    Meet us at the PDA 2022, Pharmaceutical Microbiology Conference in Washington DC

    Read More →
  • 20Sep

    Meet us at the Aseptikon 2022 Mannheim, Germany

    Read More →
  • 22Jul

    EU innovation radar launches SciFiMed project- MicroCoat proud to be part of the project!

    Read More →
  • 05Mai

    Microcoat announces the 6th Monocyte-Activation Test Proficiency Test Program

    Read More →
  • 14Apr

    30 Years Microcoat

    Read More →
  • 10Mrz

    Donation handover Ahrtal

    Read More →
  • 21Okt

    We are back!

    Read More →